Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alumis Inc. - Common Stock (NQ:ALMS)

21.33 -1.00 (-4.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 822,308
Open 22.33
Bid (Size) 20.30 (500)
Ask (Size) 23.76 (500)
Prev. Close 22.33
Today's Range 21.18 - 22.37
52wk Range 2.760 - 30.60
Shares Outstanding 53,752,223
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter ↗
This biotechnology firm develops clinical-stage therapies for autoimmune and neuroinflammatory diseases using proprietary TYK2 inhibitors. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares ↗
This clinical-stage biotech develops therapies for rare muscle diseases, leveraging its FORCE platform to target significant unmet needs. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+138.2%
+138.2%
1 Month
-13.8%
-13.8%
3 Month
-27.4%
-27.4%
6 Month
+179.2%
+179.2%
1 Year
+379.3%
+379.3%

More News

Read More
News headline image
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing ↗
Via The Motley Fool
News headline image
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗
Via The Motley Fool
News headline image
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗
Via The Motley Fool
News headline image
An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗
Via Stocktwits
Topics ETFs Government Stocks
Unusual volume stocks in Wednesday's session ↗
Via Chartmill
Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗
Via Stocktwits
Topics Stocks
Dow Clears 49,000 as AI’s “Data Deluge” Ignites a Memory-Stock Melt-Up ↗
Via Chartmill
Topics Artificial Intelligence Stocks
News headline image
Alumis Stock Hits Record High As Wall Street Cheers Phase 3 Psoriasis ‘Win’ — Analysts See Best-In-Class Potential ↗
Via Stocktwits
News headline image
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗
Via The Motley Fool
Topics Stocks
News headline image
The Great Rotation: Small-Caps Lead 2026 Market Charge as Tech Giants Stumble
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
FOCUSfactor® Beverage Emerges as a Growth Catalyst for Synergy CHC Corp. (NASDAQ: SNYR) – Alongside CYCN, ALMS, EVTV, RDZN See Why
Via AB Newswire
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
Why Is ALMS Stock Rising Today? ↗
Via Stocktwits
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Alumis’ Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program
From Alumis Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Alumis Inc. - Common Stock publicly traded?
Yes, Alumis Inc. - Common Stock is publicly traded.
What exchange does Alumis Inc. - Common Stock trade on?
Alumis Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alumis Inc. - Common Stock?
The ticker symbol for Alumis Inc. - Common Stock is ALMS on the Nasdaq Stock Market
What is the current price of Alumis Inc. - Common Stock?
The current price of Alumis Inc. - Common Stock is 21.33
When was Alumis Inc. - Common Stock last traded?
The last trade of Alumis Inc. - Common Stock was at 05/27/26 04:00 PM ET
What is the market capitalization of Alumis Inc. - Common Stock?
The market capitalization of Alumis Inc. - Common Stock is 1.15B
How many shares of Alumis Inc. - Common Stock are outstanding?
Alumis Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.